Applied Genetic Technologies Corporation (NASDAQ:AGTC) went down by -11.24% from its latest closing price compared to the recent 1-year high of $9.67. The company’s stock price has collected 0.97% of gains in the last five trading sessions. Press Release reported on 02/16/21 that AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021
Is It Worth Investing in Applied Genetic Technologies Corporation (NASDAQ :AGTC) Right Now?
Plus, the 36-month beta value for AGTC is at 2.52. Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Applied Genetic Technologies Corporation declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $16.71. AGTC currently public float of 36.25M and currently shorts hold a 3.62% ratio of that float. Today, the average trading volume of AGTC was 2.37M shares.
AGTC’s Market Performance
AGTC stocks went up by 0.97% for the week, with a monthly jump of 33.33% and a quarterly performance of 44.78%, while its annual performance rate touched 16.64%. The volatility ratio for the week stands at 23.58% while the volatility levels for the past 30 days are set at 13.54% for Applied Genetic Technologies Corporation. The simple moving average for the period of the last 20 days is 16.86% for AGTC stocks with a simple moving average of 21.30% for the last 200 days.
Analysts’ Opinion of AGTC
Many brokerage firms have already submitted their reports for AGTC stocks, with H.C. Wainwright repeating the rating for AGTC by listing it as a “Buy.” The predicted price for AGTC in the upcoming period, according to H.C. Wainwright is $24 based on the research report published on February 02nd of the current year 2021.
Cantor Fitzgerald gave a rating of “Overweight” to AGTC, setting the target price at $14 in the report published on June 23rd of the previous year.
AGTC Trading at 28.90% from the 50-Day Moving Average
After a stumble in the market that brought AGTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.47% of loss for the given period.
Volatility was left at 13.54%, however, over the last 30 days, the volatility rate increased by 23.58%, as shares surge +31.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +40.22% upper at present.
During the last 5 trading sessions, AGTC rose by +0.97%, which changed the moving average for the period of 200-days by +54.84% in comparison to the 20-day moving average, which settled at $5.41. In addition, Applied Genetic Technologies Corporation saw 52.57% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for AGTC
Current profitability levels for the company are sitting at:
- -1913.66 for the present operating margin
The net margin for Applied Genetic Technologies Corporation stands at -1870.85. The total capital return value is set at -57.03, while invested capital returns managed to touch -56.13. Equity return is now at value -89.20, with -62.30 for asset returns.
Based on Applied Genetic Technologies Corporation (AGTC), the company’s capital structure generated 20.97 points at debt to equity in total, while total debt to capital is 17.33. Total debt to assets is 14.84, with long-term debt to equity ratio resting at 19.41. Finally, the long-term debt to capital ratio is 16.05.
When we switch over and look at the enterprise to sales, we see a ratio of 20.93, with the company’s debt to enterprise value settled at 0.29. The receivables turnover for the company is 377.38 and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.40.